In addition, the predictive performance of IGF2BP2 in HNSCC was measured by receiver operating characteristic (ROC) curve analysis, with an AUC value of 0.910 (Figure 1E). This evidence concerns the gene IGF2BP2 and head and neck squamous cell carcinoma.